A solid-phase sandwich enzyme-linked immunosorbent assay for determining 0,-glycoprotein I in urine has been developed. It has a working concentration range of 5-40 pg/L and a detection limit of approximately 1 . 4 pg/L. The withinplate coefficient of variation (CV) falls between 1.4% and 2 -1 % , and the betweenbatch CV ranges from 5.2 to 6.0%. Recovery of P,-glycoprotein I added to urine varies between 96 and 110%. The assay can also be used for determining P,-glycoprotein I in serum.
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Beta-2-glycoprotein I was identified in the perchloric acid soluble fraction of human plasma in 1961.' It has a molecular mass of approximately 50 kDa and has been shown to consist of 326 amino acids with five attached glucosaminecontaining oligosaccharides.2 Several forms have been found and genetic studies indicate that three allelic variants are coded at a single gene IOCUS.~ Its physiological role is not known but it has been identified as a constituent of chylomicrons, and very-low-density and high-density lipoprotein^,^ and it is sometimes called Apolipoprotein H. 3 It is known that it can activate lipoprotein l i p a~e ,~ and that it inhibits the contact activation system in blood coagulation. 6 In the course of searching for potential new markers of renal tubular disorders, using a sensitive immunodot procedure, we discovered that &glycoprotein I could be readily detected in the urine of patients with tubular defects.
Subsequently we developed a radial immunodiffusion assay for this protein but found that it lacked the sensitivity required to detect 0,-glycoprotein I in the urine of healthy subjects and patients with minor tubular defects. This problem, together with the non-availability of further supplies of the commercial antiserum to 0,-glycoprotein I, led us to raise our own antiserum and to develop an enzyme-linked immunosorbent assay (ELISA).' Correspondence: Dr M Lapsley.
MATERIALS Specimens
Serum and random urine specimens were obtained from healthy adult volunteers and from patients with a variety of renal disorders. Urine specimens were aliquotted and stored without preservative at between -20 "C and -25 " C within 4 h of collection; under these conditions 0,-glycoprotein I has been shown to be stable for at least 2 years.8
Reagents
Horseradish peroxidase, salts for making phosphate-buffered saline, polyoxyethylenesorbitan monolaureate (TWEEN ZO), and o-phenylenediamine were all obtained from Sigma Chemical Company Ltd (Poole, UK). Bovine serum albumin fraction V was obtained from ICN Biomedicals Ltd (High Wycombe, UK). Lyophilized purified human serum P,-glycoprotein I, standard human serum containing 230 mg/L P,-glycoprotein I, control plasma containing 160 mg/L 0,-glycoprotein I , and rabbit antihuman-&-glycoprotein I were obtained from Behring (Marburg, Germany). All other chemicals, which were of Analytical Grade or better, were obtained from British Drug Houses Ltd (Poole, UK). Freund's complete and incomplete adjuvants, and Nunc Maxisorp F96 flatbottomed polystyrene microtitre plates were obtained from Gibco Ltd (Uxbridge, UK).
Antiserum to 8,-glycoprotein-1
An antiserum to human P,-glycoprotein I was raised in rabbits. Six rabbits were immunized; they were initially given 200pg of the purified human protein in complete Freund's adjuvant by multiple intradermal injections, and 30 days later they were given a similar dose, again by multiple intradermal injections, but this time in Freund's incomplete adjuvant. Bleeding was performed 15 days after the second dose. Titres were checked by Ouchterlony immunodiffusion and sera with titres lower than the Behring antiserum t o P,-glycoprotein I were discarded. The specificity of each of the acceptable antisera was tested both by imrnunodiffusion procedures and by a combined isoelectric focusing and immunoblotting procedure similar to that described in another c~n t e x t ;~ no reaction was detected with purified preparations of human albumin, Gc-globulin p2 microglobulin, q microglobulin and lysozyme, and only slight reactivity with transferrin and a I acid glycoprotein (see Results section). Suitable antisera were then pooled and purified by ion exchange chromatography using a column of Whatman DEAE 52 cellulose. The titres of the eluted IgG fractions were checked on Ouchterlony plates and suitable fractions were pooled and then lyophilized for subsequent use. Some of the IgG antibody material was conjugated with horseradish peroxidase by the periodate method of Wilson and Nakane.lo Aliquots of both the conjugated and unconjugated antibodies were stored frozen at between -2 0°C and -25 "C.
Equipment
For pipetting into the microtitre plates, an Eppendorf multipipette with a Plus/8 eightchannel adaptor was used except for the addition of antigen, for which a Hamilton Microlab M computer-controlled diluter/dispenser was used. For the washing, agitation, and reading of the 96-well microtitre plates, an Ultrawash I1 automated washer, a Shaker-Incubator and a MR700-Microplate Reader, all from Dynatech Laboratories (Billingshurst, UK) were used, respectively. The microplate reader was linked to a DSC Turbo (IBM compatible) personal computer for on-line transfer of the optical density readings to the Dynatech Immunosoft System, which uses a third order semilogarithmic function t o construct a best-fit calibration curve, and also calculates the results.
METHODS
For comparative purposes, 0,-glycoprotein I was measured by a radial immunodiffusion procedure as well as by the new ELISA method.
Radial imrnunodiffusion procedure
This followed the general procedure of Mancini, Carbonara and Heremans." The gel contained 100 pL of Behring anti-human-&-glycoprotein I in 10mL of 1 % agar, and standards within concentration ranges of 4.8 to 38 and 19.2 to 57.5 mg/L were prepared in 9 g/L sodium chloride from Behring standard serum. Unknown samples were examined in duplicate, after dilution as necessary. The method is capable of measuring P,-glycoprotein I at concentrations of 4.8 mg/L or above; below this level the precipitin rings are difficult to read.
New assay procedure

Coating of wells of microtitre plate with capture antibody
The unconjugated rabbit anti-0,-glycoprotein I antibody was diluted 1 in 500 with 50mmol/L carbonate/bicarbonate buffer pH 9 -6 and 100 pL was pipetted into each well of a 96-well microtitre plate. A column of eight wells was filled at a time, starting from the left-hand side of the plate. When dispensing was complete, which takes less than 10 s, the plate was wrapped in Clingfilm and left at room temperature (approximately 20 "C) in the dark for 2-6 h.
Washing of coated plate
To remove unbound unconjugated antibody, each well was washed 10 times with 200 pL of a wash solution containing 10 g/L sodium chloride and 1 mL/L of Tween-20 in distilled deionized water. The automated washer, which washes all 96 wells simultaneously, was used for this process and each wash was of 20 s duration. The washed plate was subsequently rinsed three times in distilled deionized water, dried by tapping vigorousby whilst inverted over a paper towel and used immediately.
Addition of antigen
Unknown samples and control specimens were routinely diluted in assay buffer solution duplicate 100 pL aliquots of the diluted control and unknown samples, and of the &glycoprotein-l standards and the assay buffer (for blanks), were dispensed into the wells according to the specific layout shown in Fig. 1 , a n operation that takes approximately 10 min. The six standards used, prepared by making serial threefold dilutions in assay buffer of a working solution of purified 0,-glycoprotein I, contained 362, 121,40, 13,4-5 and 1.5 pg/L of the protein; standards extending well beyond the used part of the calibration curve were included to obtain better curve fitting using the Dynatech software. On completion of the dispensing of antigen the plate was agitated briefly, wrapped in Clingfilm and left overnight at room temperature in the dark.
Washing of plate containing captured antigen
The following morning the plate was washed, rinsed and dried as described above.
Addition of enzyme-linked antibody
One hundred microlitres of the horse-radishperoxidase-conjugated antibody, diluted 1 in 10 OOO in assay buffer solution, was pipetted into each well. The antibody was dispensed into a column of eight wells at a time starting from the left-hand side and when the addition had been made to all the wells, the plate was agitated briefly, wrapped in Clingfilm and left at room temperature for 1 h.
Washing of plate containing antigedantibody complex
At the end of the hour the plate was washed, rinsed and dried as before. in the production of a yellow colour, was stopped by the addition of 100 pL 2 mol/L sulphuric acid to each well; the acid was dispensed in the same way and in the same order as the ophenylenediamine, and the plate was agitated to ensure thorough mixing. The plate was then covered and left in the dark for 2 min to allow the menisci to stabilize.
Absorbance reading
Using the Dynatech automatic plate reader the absorbance of each well was measured at 490 nm against 630 nm as reference.
Calculation of results
After validating the calibration curve the software calculated the final result for each replicate by interpolation. The average of the results, corrected for the initial dilution, was taken as the final concentration. To reduce the effects of the variable concentration of the urine specimens, urinary &-glycoprotein I was expressed as micrograms per mmol of creatinine; the latter substance was determined by a kinetic Jaffe procedure. Serum concentrations were expressed in milligrams per litre.
RESULTS
The new ELISA was evaluated for non-specific binding, specificity, working range and linearity, precision, recovery and compared with a previously used radial immunodiffusion procedure.
Non-specific binding
Assays performed when omitting either the capture antibody or the antigen showed that nonspecific binding of antigen to the solid phase only occurred at concentrations above the linear part of the calibration curve, and that non-specific binding of the conjugated antibody to both the solid phase and to the capture antibody was virtually zero.
Specificity
The significance of any possible cross reaction by the antibody with proteins commonly encountered in human urine was investigated by performing the assay on solutions of purified preparations of six such proteins in assay buffer. The assays were carried out at six concentrations obtained by making serial doubling dilutions; the most concentrated solutions placed in the wells contained 500 mg/L Gc-globulin, 100 mg/L albumin, 100 mg/L transferrin, 50 mg/L a, acid glycoprotein, 10 mg/L p2 microglobulin, or 480 pg/L a, microglobulin. Only transferrin and al acid glycoprotein at concentrations of 12-5 mg/L or above produced any reaction, and at levels of 50 mg/L these proteins produced readings respectively equivalent t o only 3 1 . 5 pg/L and 21 pg/L of 0,-glycoprotein 1, the ratios of reactivity being 1:1587 and 1:2381. Since patient specimens are always diluted before assay, such levels of interference would not occur in practice.
Working range
Typical examples of a standard calibration curve and of the absorbance values obtained on serial dilutions of a specimen of urine are shown in Fig. 2 . This shows that the linear region of the standard curve extends over the range 5-200 pg/L but that the absorbances obtained on serial dilution of urine specimens only parallel the standard calibration curve over the range 5-40 pg/L.
The absorbances obtained with serial dilutions of serum specimens behaved similarly. When the value for one or other of the original dilutions of an unknown urine or serum sample falls outside the range 5-40 pg/L, the specimen should be re-assayed at different initial dilutions. Only when the absorbance values of both dilutions fall on this part of the curve and the two results are found t o be consistent, should the result be accepted.
Sensitivity
The detection limit of the assay, defined as the minimum level producing an absorbance greater than that of the mean plus two standard deviations of the blank values, was determined to be 1.4 pg/L. Samples yielding results below 5pg/L were however always re-analysed at a lesser initial dilution.
Precision
The within-plate precision of the assay was assessed by repeating the measurement of the &glycoprotein I concentration 32 times on three urine specimens which had been diluted to contain 5.35, 19.8 and 4 l p g / L of the protein. The coefficient of variation (CV) of the results varied between 1.4% and 2 -1%. The between-batch reproducibility was determined by measuring the P,-glycoprotein I concentration in two diluted urine specimens 25 times over the course of as many days; these specimens had been diluted to contain 5 and 40pg/l of the protein, and the between-batch CVs of the results were 5.2 and 6.0070, respectively.
Accuracy
In the absence of appropriate reference material, accuracy was assessed by comparing the value obtained on a commercial control plasma with that ascribed, and by investigating the quantitative recovery of &glycoprotein I added to specimens of urine. The mean of six results obtained on the control plasma available from Behring which has an ascribed value of 160 mg/L was 148 mg/L, i.e. 92.5% of the expected value.
In eight experiments in which small quantities of sera were added to three urine specimens (originally containing 419, 433 and 513 pg/L of &glycoprotein I) to raise the concentration by between 215 and 2150pg/L, the recovery of added &glycoprotein I varied between 96.4% and 110.2%, the mean recovery being Enzyme-linked immunosorbent assay (mg/Ll
FIGURE 3 . Plof showing the relation befween PIglycoprotein I assay results obtoined on 17 urine specimens by the new enzyme-linked immunosorbent procedure and by a radial immunodiffusion method.
Only 16 poinfs are apparent as two are coincidenf.
Comparison with radial immunodiffusion method
A comparison of the results obtained by the radial immunodiffusion and ELISA assays is shown in Fig. 3 ; only 17 comparisons were possible as relatively few patients produce urine specimens containing sufficient P,-glycoprotein to be measurable by the former procedure. Figure 3 shows that there is a close correlation between the results produced by the two methods, the correlation coefficient being 0-99, but that a systematic bias exists between them such that the results obtained by the radial immunodiffusion method are consistently lower. A comparison of results obtained on 23 sera, which required much higher initial dilution for the ELISA procedure, yielded a correlation coefficient of 0.83 but showed a similar bias towards lower results by the radial immunodiffusion method.
Reference range
Beta-2-glycoprotein I was measured in random urine specimens obtained from 35 healthy adults, 18 men aged 22-44 years, and 17 women aged between 21 -44 years. The concentration values found ranged between 40 and 530 pg/L, the mean concentration being 193 pg/L. The excretion rates per mmol of creatinine ranged between 7 and 31 pg/mmol, the mean and median being 16.9 and 17 pg/rnmol, respectively. As the frequency distribution of the excretion rates per mmol of creatinine showed skewing to the right the reference range, based on the mean plus or minus two standard deviations, was calculated after logarithmic transformation, and was determined to be 6-9-34.5 pg/mmol of creatinine. Serum concentrations of P,-glycoprotein I were measured in 28 healthy subjects, 14 men aged 22-49 years, and 14 women aged 21-43 years. The distribution of results was Gaussian but one exceptionally low outlying value of 107 mg/L, regarded as possibly belonging to a heterozygote for an abnormal &-glycoprotein I gene, was excluded before calculation of the mean and standard deviation which were 193 and 21.5 mg/L, respectively, giving a reference range of 150-236 mg/L (mean & 2 SD). No difference between the sexes was apparent in either the urine or serum results.
DISCUSSION
The procedure described for measuring &glycoprotein I shares all the usual advantages of ELISA techniques. It is simple, amenable to semi-automation, uses only small quantities of reagents, and has high sensitivity and satisfactory specificity. Further, it has none of the disadvantages of radio-immunoassays, such as a relatively limited shelf life for expensive reagents. The precision of the method compares favourably with that achieved by similar urine protein and the accuracy of the results appears to be very satisfactory.
The procedure specified for each step in the final protocol was determined by experiment. For instance, the conditions finally chosen for coating the wells with rabbit anti-fi,-glycoprotein I. emerged after trials of differing concentrations of antibody, different buffers, and varying times and temperatures of incubation. While using the least amount of antibody they achieve the binding of an adequate quantity of anti-P,-glycoprotein I to the solid phase in 2-6 h with less than 2% variation.
In performing the assay, rigid adherence to a standard protocol is essential and attention to detail is important. For instance, failure to restrict the use of the agitator to short bursts for the purpose of mixing the well contents was shown to account for variable optical density readings being obtained, as excessive agitation causes the formation of large unstable menisci which break down at variable times in relation to the reading operation. Similarly the efficiency of the washing steps is of crucial importance; an unexpected high optical density reading was often traced to a blocked nozzle in the washer.
When developing the assay we became aware of the occurrence of poor duplicates which apparently could be related t o their position on the plate and which seemed particularly noticeable when replicates were not adjacent and when wells near the edge were used; sometimes gradients were noted in both plate dimensions. This is a phenomenon that is well recognized and has been attributed to a lack of uniformity in the polystyrene of the ~1 a t e s . l~
We felt obliged to exclude other causes and so the equipment used was carefully tested for satisfactory performance by appropriately designed experiments. No equipment faults to account for the poor duplicates were discovered and we therefore investigated different ways of pairing sample replicates and placing the standards on the plates so as to minimize the position-dependent variation in their final optical density readings. Different layouts were assessed by placing the same standard or test sample in all the wells used for unknowns. The least variation was obtained by positioning replicates equidistantly and diagonally about the centre of the plate. With the pattern of dispensing duplicates of the standards and unknowns finally chosen (Fig. l) , and calculating test sample values individually for each specimen of a duplicate pair before averaging them to produce a final result, the CV of the final values for all the replicates of the same standard or test sample was reduced to under 3%; this was shown to apply to standards containing 10, 40 and 120pg/L and to urine samples containing I, 13 , 25 and 40pg/L of 0,-glycoprotein 1. The adopted pattern of dispensing into the wells reduced our between-assay CV very significantly, e.g. from 23% to 5% in the case of a specimen containing 40pg/L. A similar solution to this problem was suggested by Stemshorn et a1. 15 The partial lack of parallelism with the standard calibration curve when specimens with high concentrations of &glycoprotein I are assayed in serial dilution, suggests that interference with the antibody/antigen reaction occurs in certain circumstances. We considered the possibility that P,-glycoprotein I molecules might be forming dimers or polymers, or complexing with other proteins, when present at relatively high concentrations in a biological matrix; however, we have shown that when urine is subjected to gel filtration, &glycoprotein I elutes as a single peak in a position corresponding to a molecular mass of 50 kDa.8
The systematic difference between the results produced by the radial immunodiffusion and ELISA methods is puzzling. Initially we postulated that the discrepancy might be attributable to differences between the antibodies used, but when we replaced the commercial antiserum used in the radial immunodiffusion method by the antiserum used in the ELISA assay, the bias to lower results with the immunodiffusion method was still observed. The discrepancy is likewise not adequately explained by differences between the standards used, because when the Behring human serum standard that was used for preparing the radial immuno-diffusion standards was analysed by the ELISA procedure, after appropriate dilution, it yielded a result of 219mg/L, i.e. 92.5% of the expected value of 230 mg/L.
We have shown by immunoblotting following isoelectric-focusing, that urinary 0,-glycoprotein I not only exhibits marked heterogeneity, but also that the forms present in urine show marked differences from those present in normal serum and the purified protein.x These differences are possibly related to differences in the carbohydrate components of the molecule. In the presence of such heterogeneity, selecting a &glycoprotein I preparation to use for standardization of the assay presents a serious problem. Beta-2glycoprotein 1 isolated from pooled urine specimens is unlikely to provide a perfect standard for urinary assays because it is probable that excretion of the different forms of the protein will vary according to the state of the negative charge barrier of the glomeruli to protein filtration. 8 The purified material we are using must be regarded as an arbitrary standard but has the virtue of stability.
